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Inrecent years,endoscopicultrasoundtechniques withFineNeedle Aspiration(FNA)havebecomeanincreasinglyuseddiagnostic
aid in the diﬀerentiation of mediastinal lymphadenopathy. Endobronchial ultrasound (EBUS) and endoesophageal ultrasound
(EUS)arenowavailableforcliniciansto reach mediastinalandparamediastinalmassesusingaminimallyinvasiveapproach.These
techniques are an established component for diagnosingand staging lung cancer and their beneﬁt in the diagnosis of lymphoma’s
has been highlighted in a number of case studies. However, the lack of tissue architecture obtained by cytological FNA specimens
decreases the diagnostic accuracy for benign causes of thoracic lymphadenopathies, lymphomas,and histopathologicalsubtyping
of lung cancer. Accordingly, our study group have adapted the FNA sampling technique, resulting in tissue fragments that can be
used for histopathological examinations. As an illustration, we report a case of follicular non-Hodgkin lymphoma, diagnosed on
tissue fragments obtained by adjusted EUS FNA. We believe that this relatively simple adjustment to routine FNA sampling can
help to overcome the diagnostic limitations inherent in cytology obtained by routine FNA.
1.Background
The pathophysiology of mediastinal lymphadenopathy is
multifactorialwith bothbenignandmalignant diseases caus-
ing their presentation. Examples of benign diseases include
reactive lymphadenopathy and granulomatous diseases (e.g.,
sarcoidosis,tuberculosis,histoplasmosis).Malignantdiseases
include metastatic spread of carcinoma to the lymph nodes
or localisation of lymphoma.
Recently, the diagnosis of mediastinal lymphadenopathy
has been achieved with a combination of endoscopic ultra-
sound and Fine Needle Aspiration (FNA) techniques [1].
Clinicians are able to reach mediastinal and paramediastinal
lymphomas/ masses with endobronchial ultrasound (EBUS)
and endoesophageal ultrasound (EUS) using a minimally
invasiveapproach.However,thecombinationofimagingand
FNAtissue sampling is essential because imaging alone is not
suﬃcient for a diagnosis [1].
Nonetheless, despite a high diagnostic yield using this
combinationtechnique,thesigniﬁcant number offalse nega-
tive ﬁndings in the cytology remains problematic. A number
of studies examining epithelial malignancies have been
conducted that highlight this predicament [1–3].
It has been suggested that the generation of signiﬁcant
false negative results can be explained by sampling error and
detection error. For example, the correct node is sampled
but the material obtained does not represent the underlying
disease or the radiological suspicious node is not identiﬁed
correctly during ultrasonography. In addition, only cytology
is collected when EUS FNA is used and in the speciﬁc diﬀer-
ential diagnosis of lymphoma, due to the need to perform
immunohistopathological examinations, histological sam-
pling is preferential [4]. Moreover, in nonsmall cell lung can-
cer,thehistopathologicalsubtypinghasbeenrecognisedasof
pivotalimportanceinthechoiceofchemotherapeuticagents.
In addition, studies have shown how EUS [5]a n dE B U S
[6]can be applied forthe diagnosis oflymphoma. Some cen-
t r e su s et r u ec u tb i o p s i e st oa c q u i r el a r g e rt i s s u es p e c i m e n s ,
although it should be noted that this was not incorporated
into general clinical practice [6]. Some centres also demon-
strated the net beneﬁt of ﬂow cytometry in increasing the
diagnostic yield, particularly for lymphoma. However, for a2 Journal of Oncology
multiplicityofreasonsthistechniquecannotbeincorporated
into the general handling of all FNA samples [6].
Therefore, in the case of mediastinal lymphadenopathy
and a suspicion of a lymphoma, current medical practice
dictates that a surgical biopsy is the preferred diagnostic
approach. However, mediastinoscopy is a more invasive pro-
cedure with a higher complication rate when directly com-
pared to endoscopic ultrasound techniques [7].
Consequently, adaptations to standard EUS-FNA have
been developed in order to increase the diagnostic yield
of EUS-FNA. Subtle adaptations in both our EUS proce-
dure and in our handling of samples have allowed us to
obtain histology-like material from EUS-FNA, from which
immunohistochemistry can be performed. With the aid of
a case study, we illustrate how we were able to diagnose the
localisation of a follicular non-Hodgkin lymphoma (NHL)
on tissue fragments obtained using EUS FNA.
2.CaseReport
A 64-year-old female patient with a 30-pack-year smoking
history was admitted to the outpatient clinic for analyses of
a hilar and mediastinal lymphadenopathy. Her past medical
history revealed a follicular NHL stage IVa diagnosed in
2003. This disease presented with iliac lymphadenopathy
and bone marrow localisation. She was initially treated with
palliative radiotherapy for lymphoma in the left iliac area.
In 2007, there was clinical evidence of disease progression
based on palpable lymph nodes in the right iliac and the left-
sided supraclavicular areas. A computed tomography (CT)
of the abdomen also showed para-aortal lymphadenopathy.
She underwent palliative radiotherapy on the right iliac
lymphomatotreatitssymptomatic masseﬀect.InSeptember
2008, she was admitted for dyspnoea and a loss of appetite
and a subsequent CT scan of the thorax, neck, and abdomen
was performed. The CT scan revealed massive left hilar
lymphadenopathy with compression of the surrounding
bronchial and venous structures and mediastinal (subcari-
nal) and parasternal lymphadenopathy with a small left
sided pleural eﬀusion. A subsequent positron emission
tomography(PET)scanshowed multifocaldisease activityin
thepathologicalareascorresponding tothepreviousCTscan
and low disease activity in the para-aortal region. Nonethe-
less, despite these extensive radiological investigations it was
not possible to diﬀerentiate between progression of NHL or
another disease pathology such as an underlying primary
lung carcinoma.
Accordingly,a bronchoscopy was performed thatshowed
a slightly oedematous bronchial mucosa in the left lower
lobe. Brushing, bronchial lavage and endobronchial biopsies
oftheoedematousmucosawithatransbronchial needleaspi-
ration (TBNA) of the subcarinal node and a pleuracentesis
were performed. Further sampling of the left sternal mass
with transthoracic FNAwas also conductedbut all these tests
failed to deliver a diagnosis.
Therefore, it was deemed necessary to perform an EUS-
FNA with material being obtained from the subcarinal
lymphoma location7and from thepossible primary process.
Both aspirations delivered macroscopic “worm-like” mate-
rial. From this material, there were small tissue fragments
on which the pathologist was able to perform histological
analysis and immunohistochemical tests clearly showing
localisation of the follicular lymphoma.
3. EUS Procedure
EUS was performed according to published guidelines with
an Olympus EUS EXERA ultrasonic video gastroscope GF-
UC160P-OL5. After identiﬁcation of the suspected lymph
node, the FNA needle was introduced (model Olympus NA-
200H-8022needle width 22Gauge).Following inﬁltration of
the node, the mandarin was pulled back and in excess of
15 passes into the lymph node were performed before the
needle was ﬁnally retracted. The mandarin was reintroduced
to push any collected tissue fragments, that possessed a
“worm-like” appearance, into acytorichred (CRR)medium.
Finally,afterthemandarin wasremovedagain, theremaining
droplets were collected on glasses by clearing the needle with
air, using a 20cc syringe.
This procedure resulted in the collection of:
(i) “Worm-like” coherent material in the CRR,
(ii) Air dried smeared droplets on glasses, and
(iii) Cytospin ﬂuid after the “worm-like” material was
extracted.
These materials were then processed and investigated as
follows
(1) Cytological examination was performed on II and
III, using May Gr¨ unwald-Giemsa colouring and
Shandon EZ Megafunnel (Thermo Fisher) method
with Papanicolaou colouring, respectively.
(2) The “worm-like” fragments in CRR (I) were added
to liquid agar, compressed on the bottom of a mold
andleftforsolidiﬁcation.Thesolidiﬁedagar wasthen
taken out from the mold and encased in a cassette.
The cassette was further processed according to rou-
tine histological investigative techniques. The follow-
ing day, two slices were made at two diﬀerent levels
allowing standard and supplemental histological and
immunohistochemical staining to be performed.
Our approach represents a subtle but signiﬁcant adapta-
tion to the routine handling of this material as a smear is not
madefromthe“worm-like”fragment. Byusingourmodiﬁed
technique,we cangeneratetwoimportant advantages; ﬁrstly,
it allows optimal use of the collected material including
histological investigation. Secondly, it leads to a reduction
in processing time owing to a reduction in the number of
smears that are made.
We opted to collect the material in CRR and not dire-
ctly in formalin solution for the following reasons: ﬁrstly,
due to the characteristics of CRR (ﬁxation, haemolysis,
denaturation of proteins, and compatibility with immuno-
histochemical staining), aspecimen ofsuperiorqualitycould
be obtained. Secondly, cytological examination could be
performed on the diagnostic material in the CRR, after theJournal of Oncology 3
Figure 1: True tissue fragment of the material acquired with
adjusted EUS-FNA (HE 200×).
Figure 2: True tissue fragment of the material acquired with
adjusted EUS-FNA (HE 400×).
“worms” were removed, using the Shandon EZ Megafunnel.
T h i sp r o c e s si sp a r t i c u l a r l ya d v a n t a g e o u sa si ti sb o t hq u i c k
and the equipment is relatively simple to use. Conversely,
using an alternative formalin solution would have made the
process markedly more complicated.
However, it should be noted that in our aforementioned
example, the cytological material referred to in II and III did
not contribute to the diagnosis of lymphoma. Nonetheless,
histological tissue fragments that were intact and possessed
structural integrity, as illustrated in Figures 1, 2,a n d3,w e r e
obtained from step I coherent material in CRR. Therefore, a
subsequent diagnosis of follicular non-Hodgkin lymphoma
could be made after immunohistochemical staining.
4.Discussion
Endoscopic ultrasound is a well-established component in
the diagnosis of lung cancer with most clinicians utilising
EUS as part of their routine diagnostic testing. Furthermore,
a growing body evidence highlights the additional beneﬁts
of EBUS [8]. The application of EUS provides minimally
invasive access to the lymph nodes in the posterior medi-
astinum, especially on the left side (Mountain-Dressler 2, 4,
5, 6, 7, 8, 9.) and the left-sided adrenal gland. Recent studies
have shown a high accuracy in diagnosing mediastinal
lymphadenopathy of unknown origin and benign disorders
Figure 3: Immunohistochemical stain CD79A (HE 400×). Micro-
scopical report: histological tissue fragments are presented. The
image is determined by small lymphatic cells with irregular shaped
nucleoli. The chromatine-pattern is enlarged. There is indentation
on multiple sides. Some B-lymfoblasts are seen (CD79A/20). The
totalimageisrepresentativeofafollicularnon-Hodgkinlymphoma.
such as sarcoidosis [9]. However, the lack of tissue architec-
ture obtained by cytological FNA specimens decreases the
diagnostic accuracy, and accordingly suggestions have been
proposed to alleviate this problem.
One current suggestion is that a true cut needle for
obtaining tissue fragments (TCB) should be used. In a small
study, Storch et al. [2] demonstrated in a subgroup of 19
patients with a benign disorder, that the combination of
FNA and TCB achieved 100% diagnostic accuracy and that
TCB was superior over FNA (89% versus 68%, resp.) in an
accuratediagnosis. AlthoughtheuseofTCBtoretrievelarger
histological biopsies has been described in the thorax, it is a
new technique and large trials have not yet been conducted
that provide satisfactory evidence that this approach is safe.
Evidence for its eﬃcacy and safety has only been provided
by a few small trials and case reports. Nonetheless, arguably
the greatest limitation in EUS-TCB is the necessity that
the mediastinal mass must be larger than two centimetres
without vascular involvement. Masses that fall outside these
stipulated prerequisitions cannot yield a suitable sample
using EUS-TCB but signiﬁcantly it can be achieved using
EUS-FNA.
Further techniques to increase the diagnostic yield are
centred on the handling of the samples. In our approach,
smears are not created and instead the samples are trans-
ferred directly to a medium in an eﬀort to maintain tissue
architecture. Moreover, these “worms” that are collected
using our technique can then be used for histopathological
analysis. To retrieve these “worms”, the number of needle
passes per puncture into the abnormal structure is of
importance. It was determined that the optimum number of
passes perpuncturetoobtainthe“worm-like”structureswas
at least 10, as less than 10 passes failed to generate suﬃcient
data (results not shown). However, it is important to realise
that a degree of structural integrity is required to collect
the histological material. In necrotic areas, for example, this
integrity is lacking and it is not always possible to obtain the
required “worm-like” material that is needed for analysis.4 Journal of Oncology
Theoretically, more passes could be associated with a
higher complication rate but this was not found in our
series. Previously, we have performed over 300 procedures
using this technique and only 1 complication occurred and
this was believed to be related to the puncture itself rather
than the number of passes [10]. Additional testament to the
safety of this technique is provided in another paper that we
have published that examined the capability of performing
spectroscopy during EUS-FNA. The results showed that no
adverse events were experienced by our study population
[11].
In the last year, a number of reports on the diagnostic
accuracy of EUS and EBUS in the diagnosis of lymphoma
have been published [5, 6, 12, 13]. As large randomized
studies are lacking, the interpretation of the results and
diagnostic yield is confounded by the incidence in the study
population [14].
Diagnostic yield is also determined in part by the
protocols and techniques implemented by the individual
institution. For example, if “on-site” cytology is performed,
in the event that lymphoma is suspected, additional punc-
tures should be performed to allow for subsequent ﬂow
cytometry investigations.
However, as we have shown that our diagnostic yield
is increased by extracting and sampling the “worm-like”
material, we no longer perform on-site cytology.
In our case study, conventional diagnostic techniques
would have required the use of CT-guided transthoracic
biopsy for sampling the mass in the left lower lobe of the
lungs and mediastinoscopy to investigate the mediastinal
lymphomas. Therefore, our modiﬁed technique not only
eliminates the need for these separate procedures, but it also
allows both sites to be sampled in one session.
The case study provided illustrates the use of our modi-
ﬁedtechniqueindiagnosingNHLbutitsusecanbeextended
to provide diagnostic subtyping of nonsmall cell lung cancer.
This application is important because it allows the optimum
treatment regime forpatientsto be determined.Ouradapted
technique is now currently utilised in a number of other
hospitals and this has generated similar results. We now
have a small series of 6 patients who were diagnosed with
lymphoma; using this technique, no further investigations
were deemed necessary. In a series of 92 lung cancerpatients,
75% of samples could be investigated for histological sub-
typing, morphological examination, immunochemistry, and
EGFR mutation analysis with EUS-FNA samples. With our
simple but highly eﬀective adjustments in standard EUS-
FNA, the diagnostic yield could be increased and the need
for subsequent surgical and radiological sampling could be
eliminated.
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